filmov
tv
To Switch or Not: Biosimilars in Inflammatory Arthritis
Показать описание
Dr. Jonathan Kay reports on abstract 1112 at ACR22 Convergence.
RheumNow
Rheumatoid
arthritis
Rheumatology
Lupus
Vasculitis
Рекомендации по теме
0:02:57
To Switch or Not: Biosimilars in Inflammatory Arthritis
0:29:22
To Switch or Not to Switch: Patient Case Discussions on Integrating Biosimilars in Multiple Scler...
0:04:53
Biosimilars and the Issue of Interchangeability
0:02:03
Biosimilars Interchangeability
0:02:23
What to Know Before Switching from Biologics to Biosimilars?
0:02:41
Switching to Biosimilars 2021
0:01:08
The Impact of Switching from a Reference Biologic to a Biosimilar
0:03:30
Understanding Non-Medical Switching: Innovator Biologics and Biosimilars
0:04:09
Better Understanding Biosimilar Medications
0:57:53
Biosimilars: What You Need to Know
0:01:36
Interchangeable Biosimilars
0:20:47
Biosimilars for IBD: Start, Switch, or Stay Away?
0:00:52
How Specialty Pharmacists Can Prepare Patients to Switch to Biosimilars
0:02:46
Switching to biosimilars.
0:53:30
Switching to Biosimilars: A conversation with Peter Taylor
0:04:21
Biosimilars - Making the switch
0:01:30
Switching from a Biologic to Biosimilar Drug for IBD in Ontario
0:12:16
Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim
0:18:23
Biosimilars for IBD: To Start, Switch, or Stay Away?
0:05:17
IBD: Switching from a Biologic to a Biosimilar
0:39:51
Why IBD Patients Should Know About Biosimilars
0:02:28
What are Biologic and Biosimilar Drugs?
1:09:11
Biosimilars: What You Need to Know
0:02:21
Switching from a Biologic to a Biosimilar Drug in Canada